世界の双極性障害市場規模・現状・予測2021-2027

【英語タイトル】Global Bipolar Disorder Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0853)・商品コード:QY21APR0853
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:93
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,053,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、双極性障害の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(双極I型障害、双極性II型障害、気分循環性​​障害)、用途別市場規模(気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・双極性障害の市場動向
・企業の競争状況、市場シェア
・双極性障害の種類別市場規模(双極I型障害、双極性II型障害、気分循環性​​障害)
・双極性障害の用途別市場規模(気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬、その他)
・双極性障害の北米市場規模2016-2027(アメリカ、カナダ)
・双極性障害の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・双極性障害のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・双極性障害の中南米市場規模2016-2027(メキシコ、ブラジル)
・双極性障害の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Glaxo SmithKline (GSK)、Pfizer Inc.、Janssen Pharmaceuticals、Eli Lilly、Allergan Plc.、Novartis AG、AbbVie Inc.、Otsuka Holdings Ltd、AstraZeneca)
・結論
【レポートの概要】

Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.

Market Analysis and Insights: Global Bipolar Disorder Market
The global Bipolar Disorder market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bipolar Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bipolar Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bipolar Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bipolar Disorder market.

Global Bipolar Disorder Scope and Market Size
Bipolar Disorder market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Bipolar I Disorder
Bipolar II Disorder
Cyclothymic Disorder

Segment by Application
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bipolar I Disorder
1.2.3 Bipolar II Disorder
1.2.4 Cyclothymic Disorder
1.3 Market by Application
1.3.1 Global Bipolar Disorder Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Mood Stabilizers
1.3.3 Anticonvulsants
1.3.4 Antipsychotic drugs
1.3.5 Antidepressant drugs
1.3.6 Antianxiety drugs
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bipolar Disorder Market Perspective (2016-2027)
2.2 Bipolar Disorder Growth Trends by Regions
2.2.1 Bipolar Disorder Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bipolar Disorder Historic Market Share by Regions (2016-2021)
2.2.3 Bipolar Disorder Forecasted Market Size by Regions (2022-2027)
2.3 Bipolar Disorder Industry Dynamic
2.3.1 Bipolar Disorder Market Trends
2.3.2 Bipolar Disorder Market Drivers
2.3.3 Bipolar Disorder Market Challenges
2.3.4 Bipolar Disorder Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Players by Revenue
3.1.1 Global Top Bipolar Disorder Players by Revenue (2016-2021)
3.1.2 Global Bipolar Disorder Revenue Market Share by Players (2016-2021)
3.2 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Revenue
3.4 Global Bipolar Disorder Market Concentration Ratio
3.4.1 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Revenue in 2020
3.5 Bipolar Disorder Key Players Head office and Area Served
3.6 Key Players Bipolar Disorder Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bipolar Disorder Breakdown Data by Type
4.1 Global Bipolar Disorder Historic Market Size by Type (2016-2021)
4.2 Global Bipolar Disorder Forecasted Market Size by Type (2022-2027)

5 Bipolar Disorder Breakdown Data by Application
5.1 Global Bipolar Disorder Historic Market Size by Application (2016-2021)
5.2 Global Bipolar Disorder Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bipolar Disorder Market Size (2016-2027)
6.2 North America Bipolar Disorder Market Size by Type
6.2.1 North America Bipolar Disorder Market Size by Type (2016-2021)
6.2.2 North America Bipolar Disorder Market Size by Type (2022-2027)
6.2.3 North America Bipolar Disorder Market Size by Type (2016-2027)
6.3 North America Bipolar Disorder Market Size by Application
6.3.1 North America Bipolar Disorder Market Size by Application (2016-2021)
6.3.2 North America Bipolar Disorder Market Size by Application (2022-2027)
6.3.3 North America Bipolar Disorder Market Size by Application (2016-2027)
6.4 North America Bipolar Disorder Market Size by Country
6.4.1 North America Bipolar Disorder Market Size by Country (2016-2021)
6.4.2 North America Bipolar Disorder Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Bipolar Disorder Market Size (2016-2027)
7.2 Europe Bipolar Disorder Market Size by Type
7.2.1 Europe Bipolar Disorder Market Size by Type (2016-2021)
7.2.2 Europe Bipolar Disorder Market Size by Type (2022-2027)
7.2.3 Europe Bipolar Disorder Market Size by Type (2016-2027)
7.3 Europe Bipolar Disorder Market Size by Application
7.3.1 Europe Bipolar Disorder Market Size by Application (2016-2021)
7.3.2 Europe Bipolar Disorder Market Size by Application (2022-2027)
7.3.3 Europe Bipolar Disorder Market Size by Application (2016-2027)
7.4 Europe Bipolar Disorder Market Size by Country
7.4.1 Europe Bipolar Disorder Market Size by Country (2016-2021)
7.4.2 Europe Bipolar Disorder Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorder Market Size (2016-2027)
8.2 Asia-Pacific Bipolar Disorder Market Size by Type
8.2.1 Asia-Pacific Bipolar Disorder Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bipolar Disorder Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bipolar Disorder Market Size by Type (2016-2027)
8.3 Asia-Pacific Bipolar Disorder Market Size by Application
8.3.1 Asia-Pacific Bipolar Disorder Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bipolar Disorder Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bipolar Disorder Market Size by Application (2016-2027)
8.4 Asia-Pacific Bipolar Disorder Market Size by Region
8.4.1 Asia-Pacific Bipolar Disorder Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bipolar Disorder Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bipolar Disorder Market Size (2016-2027)
9.2 Latin America Bipolar Disorder Market Size by Type
9.2.1 Latin America Bipolar Disorder Market Size by Type (2016-2021)
9.2.2 Latin America Bipolar Disorder Market Size by Type (2022-2027)
9.2.3 Latin America Bipolar Disorder Market Size by Type (2016-2027)
9.3 Latin America Bipolar Disorder Market Size by Application
9.3.1 Latin America Bipolar Disorder Market Size by Application (2016-2021)
9.3.2 Latin America Bipolar Disorder Market Size by Application (2022-2027)
9.3.3 Latin America Bipolar Disorder Market Size by Application (2016-2027)
9.4 Latin America Bipolar Disorder Market Size by Country
9.4.1 Latin America Bipolar Disorder Market Size by Country (2016-2021)
9.4.2 Latin America Bipolar Disorder Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorder Market Size (2016-2027)
10.2 Middle East & Africa Bipolar Disorder Market Size by Type
10.2.1 Middle East & Africa Bipolar Disorder Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bipolar Disorder Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bipolar Disorder Market Size by Type (2016-2027)
10.3 Middle East & Africa Bipolar Disorder Market Size by Application
10.3.1 Middle East & Africa Bipolar Disorder Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bipolar Disorder Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bipolar Disorder Market Size by Application (2016-2027)
10.4 Middle East & Africa Bipolar Disorder Market Size by Country
10.4.1 Middle East & Africa Bipolar Disorder Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bipolar Disorder Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Glaxo SmithKline (GSK)
11.1.1 Glaxo SmithKline (GSK) Company Details
11.1.2 Glaxo SmithKline (GSK) Business Overview
11.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
11.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2016-2021)
11.1.5 Glaxo SmithKline (GSK) Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Bipolar Disorder Introduction
11.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2016-2021)
11.2.5 Pfizer Inc. Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Details
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2016-2021)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorder Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Allergan Plc.
11.5.1 Allergan Plc. Company Details
11.5.2 Allergan Plc. Business Overview
11.5.3 Allergan Plc. Bipolar Disorder Introduction
11.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2016-2021)
11.5.5 Allergan Plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Bipolar Disorder Introduction
11.6.4 Novartis AG Revenue in Bipolar Disorder Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Bipolar Disorder Introduction
11.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2016-2021)
11.7.5 AbbVie Inc. Recent Development
11.8 Otsuka Holdings Ltd
11.8.1 Otsuka Holdings Ltd Company Details
11.8.2 Otsuka Holdings Ltd Business Overview
11.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
11.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2016-2021)
11.8.5 Otsuka Holdings Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorder Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2016-2021)
11.9.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bipolar Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bipolar I Disorder
Table 3. Key Players of Bipolar II Disorder
Table 4. Key Players of Cyclothymic Disorder
Table 5. Global Bipolar Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bipolar Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bipolar Disorder Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bipolar Disorder Market Share by Regions (2016-2021)
Table 9. Global Bipolar Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bipolar Disorder Market Share by Regions (2022-2027)
Table 11. Bipolar Disorder Market Trends
Table 12. Bipolar Disorder Market Drivers
Table 13. Bipolar Disorder Market Challenges
Table 14. Bipolar Disorder Market Restraints
Table 15. Global Bipolar Disorder Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bipolar Disorder Market Share by Players (2016-2021)
Table 17. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder as of 2020)
Table 18. Ranking of Global Top Bipolar Disorder Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bipolar Disorder Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bipolar Disorder Product Solution and Service
Table 22. Date of Enter into Bipolar Disorder Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bipolar Disorder Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bipolar Disorder Revenue Market Share by Type (2016-2021)
Table 26. Global Bipolar Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bipolar Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bipolar Disorder Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bipolar Disorder Revenue Market Share by Application (2016-2021)
Table 30. Global Bipolar Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bipolar Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bipolar Disorder Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bipolar Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bipolar Disorder Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bipolar Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bipolar Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bipolar Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bipolar Disorder Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bipolar Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bipolar Disorder Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bipolar Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bipolar Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bipolar Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bipolar Disorder Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bipolar Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bipolar Disorder Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bipolar Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bipolar Disorder Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bipolar Disorder Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bipolar Disorder Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bipolar Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bipolar Disorder Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bipolar Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bipolar Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bipolar Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bipolar Disorder Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bipolar Disorder Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bipolar Disorder Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bipolar Disorder Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bipolar Disorder Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bipolar Disorder Market Size by Country (2022-2027) & (US$ Million)
Table 62. Glaxo SmithKline (GSK) Company Details
Table 63. Glaxo SmithKline (GSK) Business Overview
Table 64. Glaxo SmithKline (GSK) Bipolar Disorder Product
Table 65. Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 66. Glaxo SmithKline (GSK) Recent Development
Table 67. Pfizer Inc. Company Details
Table 68. Pfizer Inc. Business Overview
Table 69. Pfizer Inc. Bipolar Disorder Product
Table 70. Pfizer Inc. Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 71. Pfizer Inc. Recent Development
Table 72. Janssen Pharmaceuticals Company Details
Table 73. Janssen Pharmaceuticals Business Overview
Table 74. Janssen Pharmaceuticals Bipolar Disorder Product
Table 75. Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 76. Janssen Pharmaceuticals Recent Development
Table 77. Eli Lilly Company Details
Table 78. Eli Lilly Business Overview
Table 79. Eli Lilly Bipolar Disorder Product
Table 80. Eli Lilly Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 81. Eli Lilly Recent Development
Table 82. Allergan Plc. Company Details
Table 83. Allergan Plc. Business Overview
Table 84. Allergan Plc. Bipolar Disorder Product
Table 85. Allergan Plc. Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 86. Allergan Plc. Recent Development
Table 87. Novartis AG Company Details
Table 88. Novartis AG Business Overview
Table 89. Novartis AG Bipolar Disorder Product
Table 90. Novartis AG Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 91. Novartis AG Recent Development
Table 92. AbbVie Inc. Company Details
Table 93. AbbVie Inc. Business Overview
Table 94. AbbVie Inc. Bipolar Disorder Product
Table 95. AbbVie Inc. Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 96. AbbVie Inc. Recent Development
Table 97. Otsuka Holdings Ltd Company Details
Table 98. Otsuka Holdings Ltd Business Overview
Table 99. Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 100. Otsuka Holdings Ltd Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Bipolar Disorder Product
Table 104. AstraZeneca Revenue in Bipolar Disorder Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bipolar Disorder Market Share by Type: 2020 VS 2027
Figure 2. Bipolar I Disorder Features
Figure 3. Bipolar II Disorder Features
Figure 4. Cyclothymic Disorder Features
Figure 5. Global Bipolar Disorder Market Share by Application: 2020 VS 2027
Figure 6. Mood Stabilizers Case Studies
Figure 7. Anticonvulsants Case Studies
Figure 8. Antipsychotic drugs Case Studies
Figure 9. Antidepressant drugs Case Studies
Figure 10. Antianxiety drugs Case Studies
Figure 11. Others Case Studies
Figure 12. Bipolar Disorder Report Years Considered
Figure 13. Global Bipolar Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Bipolar Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Bipolar Disorder Market Share by Regions: 2020 VS 2027
Figure 16. Global Bipolar Disorder Market Share by Regions (2022-2027)
Figure 17. Global Bipolar Disorder Market Share by Players in 2020
Figure 18. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Bipolar Disorder Revenue in 2020
Figure 20. Global Bipolar Disorder Revenue Market Share by Type (2016-2021)
Figure 21. Global Bipolar Disorder Revenue Market Share by Type (2022-2027)
Figure 22. North America Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Bipolar Disorder Market Share by Type (2016-2027)
Figure 24. North America Bipolar Disorder Market Share by Application (2016-2027)
Figure 25. North America Bipolar Disorder Market Share by Country (2016-2027)
Figure 26. United States Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Bipolar Disorder Market Share by Type (2016-2027)
Figure 30. Europe Bipolar Disorder Market Share by Application (2016-2027)
Figure 31. Europe Bipolar Disorder Market Share by Country (2016-2027)
Figure 32. Germany Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Bipolar Disorder Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Bipolar Disorder Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Bipolar Disorder Market Share by Region (2016-2027)
Figure 42. China Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Bipolar Disorder Market Share by Type (2016-2027)
Figure 50. Latin America Bipolar Disorder Market Share by Application (2016-2027)
Figure 51. Latin America Bipolar Disorder Market Share by Country (2016-2027)
Figure 52. Mexico Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Bipolar Disorder Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Bipolar Disorder Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Bipolar Disorder Market Share by Country (2016-2027)
Figure 58. Turkey Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Bipolar Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Glaxo SmithKline (GSK) Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 62. Pfizer Inc. Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 63. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 65. Allergan Plc. Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 67. AbbVie Inc. Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 68. Otsuka Holdings Ltd Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Bipolar Disorder Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【掲載企業】

Glaxo SmithKline (GSK)、Pfizer Inc.、Janssen Pharmaceuticals、Eli Lilly、Allergan Plc.、Novartis AG、AbbVie Inc.、Otsuka Holdings Ltd、AstraZeneca

★調査レポート[世界の双極性障害市場規模・現状・予測2021-2027] (コード:QY21APR0853)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の双極性障害市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆